Connection

Andrew Pollard to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Andrew Pollard has written about Cost-Benefit Analysis.
Andrew Pollard
Connection Strength
0.185
Cost-Benefit Analysis
  1. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study. Lancet Infect Dis. 2019 07; 19(7):728-739.
    View in: PubMed
    Score: 0.095
  2. A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty. Lancet Infect Dis. 2014 May; 14(5):426-34.
    View in: PubMed
    Score: 0.066
  3. The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations. Vaccine. 2019 05 27; 37(24):3190-3198.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.